Charles River Laboratories | CRL - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Agilent USD 282.22M 478K 2026-03
Align Technology USD 71.62M 1000 2026-06
Bio-Rad Laboratories USD 26.99M 18K 2025-12
Bruker USD 152.22M 282K 2026-03
Cardinal Health USD 235M 1000K 2026-03
Charles River Laboratories USD 48.17M 1.05M 2026-03
Cigna USD 264.6M 1.14M 2026-03
Concord Medical Services Hldg CNY 130.25M 130.15M 2025-06
CVS Health USD 1.27B 2M 2026-03
Danaher USD 702.9M 4.8M 2026-06
Dentsply International USD 200.3M 700K 2026-03
Elevance Health USD 216.84M 528K 2026-06
Humana USD 120.08M 18K 2026-06
Illumina USD 151.3M 607K 2026-06
Incyte USD 200.98M 1.03M 2026-06
Intrexon USD 0 0 2024-06
IQVIA Holdings USD 164.6M 2.3M 2026-06
Laboratory Of America USD 80.9M 1.4M 2026-06
Lakefront Biotherapeutics EUR 65.9M 0 2026-03
Lonza CHF 68.64M 0 2025-12
McKesson USD 280M 156M 2025-12
Merck EUR 434.78M 0 2026-03
Mettler Toledo International USD 20.21M 40.9K 2026-06
Novartis USD 1.9B 7.38M 2026-06
Pfizer USD 5.7B 13M 2026-03
Quest Diagnostics USD 110M 1000K 2026-06
Revvity USD 111.8M 1.57M 2026-03
Thermo Fisher Scientific USD 371.62M 1000 2026-06
United Therapeutics USD 42.16M 1.49M 2026-03
UnitedHealth USD 908.14M 468K 2026-06
Veradigm USD 106.07M 103.28M 2022-12
Waters USD 98.17M 89K 2026-03
West Pharmaceutical Services USD 70.4M 500K 2026-06